• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Bayer AG ADR

Bayer AG ADR

Bayer AG ADR BAYRY 3 Star

Last Price$151.70Day Change (%)0.96%
Open Price$152.74Day Change ($)1.44
Day Range150.77–152.9052-Week Range2.14–156.77

As of Wed 4/1/2015 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. GridPoint Energy Management System Earns Top Product of the Year Award from Environmental Leader

    GridPoint Energy Management System Earns Top Product of the Year Award from Environmental Leader

  2. Research and Markets: Agricultural Microbials Market by Type, Crop Type & Region - Global Trends & Forecast to 2019

    Research and Markets: Agricultural Microbials Market by Type, Crop Type & Region - Global Trends & Forecast to 2019

  3. Research and Markets: Blood Glucose Monitoring (BGM) Devices - Global Strategic Business Report 2015: Blood Glucose Strips, Blood Glucose Meters & Lancets

    Research and Markets: Blood Glucose Monitoring (BGM) Devices - Global Strategic Business Report 2015: Blood Glucose Strips, Blood Glucose Meters & Lancets

  4. Research and Markets: Bone Metastasis Global Clinical Trials Review, H1, 2015

    Research and Markets: Bone Metastasis Global Clinical Trials Review, H1, 2015

  5. Invesco Receives Three U.S. Lipper Fund Awards

    Invesco Receives Three U.S. Lipper Fund Awards

  6. Grain Highlights: Top Stories of the Day

    Grain Highlights: Top Stories of the Day

  7. Technavio Publishes Global Melanoma Therapeutics Market Analysis and Forecast 2015-2019

    Technavio Publishes Global Melanoma Therapeutics Market Analysis and Forecast 2015-2019

  8. Japan stocks swing down then up, as yen creates headwinds

    Japan stocks swing down then up, as yen creates headwinds

  9. Research and Markets: Regeneron and Bayer AG's Eylea (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

    Research and Markets: Regeneron and Bayer AG's Eylea (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

  10. Regeneron Wins Expanded Approval for Eye Drug Elyea

    Regeneron Wins Expanded Approval for Eye Drug Elyea

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.